Miriam B. Garcia, D.O.

Peer-Reviewed Articles

1. Chohan KL, Feng L, Cochran H, Rosenberg M, Isenalumhe L, Yilmaz E, Kim SH, Tiger YK, Torka P, Flanagan H, Castellino S, Bender JD, Kannaiyan R, Kahla J, DePriest BP, Narvel H, Heneghan MB, Catueno S, Tobon K, Fadul J, Faulkenberry P, Ayers A, Nathan S, Mubeen S, Luttwak E, Flerlage J, Norris RE, Kaur S, Tran O, Wannaphut C, Hawk A, Garcia MB, Cuglievan B, Riedell P, Mahadeo KM, Hamadani M, Diefenbach C, Bartlett N, Ahmed S. Real-World Outcomes of Nivolumab-AVD and Brentuximab Vedotin-AVD in Pediatric and Adult Advanced-Stage Hodgkin Lymphoma. British Journal of Haematology. e-Pub 2026.
2. Ayerbe C, Fan AE, Scanlan R, Raj R, Catueno S, Anwesha R, Aguirre H, McCall D, Roth M, Garcia MB, Nunez C, Sheikh IN, Garcia-Manero G, Cuglievean B, Gibson A. A new paradigm for pediatric AML: Improving the pipeline for treatments targeting cytogenetic and molecular alterations. Cancers (Basel), 2026. e-Pub 2026. PMID: 42649997.
3. Raj R, Ramakrishnan R, Vargas CR, Khalid M, Mohan GS, McCall D, Gibson A, Cuglievan B, Nunez C, Brown B, Bray M, Garcia MB. Complexities in the Diagnostic Evaluation and Treatment of Infant Hemophagocytic Lymphohistiocytosis. Hematology Reports, 2026. e-Pub 2026. PMID: 42645790.
4. Garcia MB, Paul Perales, David Santos, Ching-Wei D. Tzeng, Branko Cuglievan, Irtza Shiekh. A call for safe therapeutic and gastric interventions for adolescents and young adults with obesity and transplant-indicated leukemia. Frontiers in Oncology, 2026. e-Pub 2026. PMID: 42180052.
5. Catueno, S, Frost, M, Cuglievan, B, Gibson, A, McCall, DC, Nunez, CA, Roth, M, Malpica Castillo, LE, Garcia, MB. Uncommon Presentation and Therapeutic Strategies in Pediatric Relapsed/Refractory ALK-Positive ALCL. Journal of Pediatric Hematology/Oncology 48(3):125-127, 2026. e-Pub 2026. PMID: 41818168.
6. Frost M, Subbiah V, Cuglievan B, Garcia MB. Reconsidering Asparaginase in Leukemia Therapy. Acta Haematol, 2026. e-Pub 2026. PMID: 41824624.
7. Garcia, MB, Wang, B, Sheikh, IN, El Hajjar, G, McCall, DC, Nunez, CA, Gibson, A, Lorenzi, PL, Issa, GC, Cuglievan, B, Abbas, HA. High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition. Molecular and Cellular Proteomics 25(3), 2026. e-Pub 2026. PMID: 41621809.
8. Jiménez-Rivero M, Poche A, Haushalter K, Hudson EA, Larson D, Nikah K, Garcia MB, Roth M, Davis JN, Chandra J. Cook-Grow!: Insights from a Pilot Study on a Virtual Cooking, Gardening, and Nutrition Education Program for Childhood Cancer Survivors and their Families. J Cancer Educ, 2026. e-Pub 2026. PMID: 41762418.
9. Cohen E, Okeleji O, McCall D, Garcia MB, Nunez C, Cuglievan B, Herzog C, Razvi S, Tewari P, Douglas H, Gibson A. Synchronous Mediastinal Germ Cell Tumor with Sarcomatous Transformation and Acute Myeloid Leukemia. Pediatr Blood Cancer 72(12), 2025. e-Pub 2025.
10. Raj R, Catueno S, Gibson A, McCall D, Garcia M, Nunez C, Roth M, Sasaki K, Tewari P, Issa G, Farhat A, Connors J, Sheikh I, Nishida Y, Yi J, Stevens A, Bataller A, Bhalla K, Petropoulos D, Daver N, Kadia T, Cuglievan B, DiNardo AC. FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML. Blood, 2025. e-Pub 2025. PMID: 40971491.
11. Catueno S, Ramakrishnan R, Elitzur S, Garcia MB, McCall D, Nunez C, Roth M, Ferrajoli A, Cuglievan B, Gibson A. Lymphoid Malignancies in Ataxia–Telangiectasia: Experience with Novel Targeted Therapies. Pediatric Blood & Cancer, 2025. e-Pub 2025. PMID: 40605148.
12. He J, Munir F, Ayerbe C, Dickson S, Catueno S, Cuglievan B, Garcia M, Gibson A, McCall D, Nunez C, Roth M, Tewari P, Rodriguez N, Cortes J. Managing and Preventing Hypofibrinogenemia in Pediatric Leukemia Patients: Insights from MD Anderson Cancer Center. JPHO, 2025. e-Pub 2025. PMID: 40306291.
13. Berkman A, Andersen C, Puthenpura V, Short N, Merriman K, Swaminathan M, Cuglievan B, McCall D, DiNardo C, Nunez C, Jain N, Kadia T, Issa G, Gibson A, Garcia MB, Livingston JA, Parsons S, Hildebrandt M, Roth M. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectrum, 2025. e-Pub 2025. PMID: 40579211.
14. Corrigan K, Wu S, Gunther J, McCall D, Garcia M, Gibson A, Hildebrandt M, Ahmed S, Roth M. Trends in Radiation Therapy Use from 2004-2020 Among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev, 2025. e-Pub 2025. PMID: 40488452.
15. Ly C, Veletic I, Pacheco C, Dasdemir E, Jelloul F, Ferri-Borgongo s, Basi AV, Gomez JA, Root JL, Reville P, Quesada A, Bueso-Ramos c, Garcia MB, Burks JK, Abbas H. Multimodal Spatial Proteomic Profiling in Acute Myeloid Leukemia. NPJ Precis Oncol, 2025. e-Pub 2025. PMID: 40394148.
16. McCall D, Catueno S, Ramakrishnan R, Tewari P, Sheikh I, Gibson A, Nunez C, Garcia MB, Cuglievan B. Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia. Acta Haematologica, 2025. e-Pub 2025. PMID: 40324358.
17. Elgehiny A, Hsu A, McCall D, Gibson A, Cuglievan B, Nunez C, Garcia MB, Castellanos L, Funck A, Razvi S. Severe Hypertriglyceridemia Secondary to Long-Acting Asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia. JPHO, 2025. e-Pub 2025. PMID: 40560745.
18. Olayinka O, McCall D, Gibson A, Garcia MB, Nunez C, Roth M, Conners J, Petropoulos D, Tewari P, Cuglievan B, Sheikh IN. Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Advances, 2025. e-Pub 2025. PMID: 39993239.
19. Nash A, Nguyen C, Kawedia J, McCall D, Weinman S, Garcia MB, Roth M, Nunez C, Cuglievan B, Gibson A. Calaspargase Pegol Induced Hemolytic Anemia. Pediatric Blood & Cancer, 2025. e-Pub 2025. PMID: 39757554.
20. Okeleji O, McCall D, Gibson A, Garcia MB, Nunez C, Roth ME, Connors JS, Petropoulos D, Tewari P, Cuglievan B, Sheikh IN. Menin Maintenance Therapy for Acute Leukemia. Blood Adv, 2025. e-Pub 2025. PMID: 39993239.
21. McCall D, Alqahtani S, Budak M, Sheikh I, Fan AE, Ramakrishnan R, Nunez C, Roth M, Garcia MB, Gibson A, Daver N, Garces S, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garcia-Manero G, Cuglievan B, Kadia T. Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience. Cancers (Basel) 16(22), 2024. e-Pub 2024. PMID: 39594839.
22. McCall D, Alqahtani S, Budak M, Sheikh I, Fan A, Ramakrishnan R, Nunez C, Roth M, Garcia MB, Gibson A, Daver N, Garces S, Short NJ, Issa GC, Ravandi-Kashani F, DiNardo C, Montalban-Bravo G, Garcia-Manero G, Cuglievan B, Kadia T. Cladribine-Based Therapy for Relapsed or Refractory Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience. Cancers, 2024. e-Pub 2024. PMID: 39594839.
23. Gibson A, Dickson S, McCall D, Garcia MB, Connors J, He J, Roth M, Cesar N, Cuglievan B. Venetoclax for Pediatric Patients with Newly Diagnosed Acute Myeloid Leukemia. Pediatric Blood & Cancer, 2024. e-Pub 2024. PMID: 39152634.
24. Garcia M, Thandapani R. Nutritional intervention as adjuvant therapy for T-cell acute lymphoblastic leukemia. Blood Advances 8(20):5266-5267, 2024. e-Pub 2024. PMID: 39093954.
25. McCall D, Mohamed SF, Rodriguez-Sevilla JJ, Abuasab T, Patnaik A, Devireddy K, Arani N, Sheikh I, Jamshidi R, Gibson A, Roth M, Nunez C, Garcia M, Chien K, Loghavi S, Pierce SA, Sasaki K, Issa G, Kantarjian H, Cuglievan B, Garcia-Manero G. Characteristics and Outcomes of Pediatric, Adolescent, and Young Adult Patients with Myelodysplastic Neoplasms: A Single-Center Retrospective Analysis. Leukemia Research, 2024. e-Pub 2024. PMID: 39178611.
26. Lucas BJ, Connors JS, Wang H, Conneely S, Cuglievan B, Garcia MB, Rau RE. Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative Disorder: A Real-World Experience. Cancers (Basel) 16(15), 2024. e-Pub 2024. PMID: 39123476.
27. Cuglievan B, Kantarjian H, Rubnitz J, Cooper T, Zwaan M, Pollard J, DiNardo C, Kadia T, Guest E, Short N, McCall D, Daver N, Nunez C, Haddad F, Garcia M, Bhalla K, Maiti A, Catueno S, Fiskus W, Gibson A, Roth M, Khazal S, Tewari P, Abbas H, Bourgeois W, Andreeff M, Shukla N, Truong D, Connors J, Ludwig J, Stutterheim J, Salzer E, Juul-Dam K, Sasaki K, Mahadeo K, Tasian S, Borthakur G, Dickson S, Jain N, Jabbour E, Meshinchi S, Manero GG, Ravandi F, Stein E, Kolb E, Issa AG. Menin Inhibitors in Pediatric Acute Leukemia: A Comprehensive Review and Recommendations in Collaboration with Adult Leukemia. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
28. Okeleji O, Gibson A, Nunez C, Garcia MB, Roth M, Cuglievan B, McCall D. Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen. Pediatr Blood Cancer 71(8):e31091, 2024. e-Pub 2024. PMID: 38840433.
29. Nash A, Weirda W, Cuglievan B, Garcia M, McCall D, Nunez C, Albritton K, Gibson A. Rare Case Presentation of Chronic Lymphocytic Leukemia in an Adolescent Treated with Targeted therapy. Pediatric Blood and Cancer, 2024. e-Pub 2024. PMID: 38872414.
30. Alqahtani S, Ramakrishnan R, E S, Wang SA, Nunez C, McCall D, Garcia MB, Roth ME, Cuglievan B, Gibson A. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia. Pediatr Blood Cancer 71(8):e31123, 2024. e-Pub 2024. PMID: 38837565.
31. Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, Roth M, Ragoonanan D, Connors J, Herzog CE, Cuglievan B, Garcia MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatr Blood Cancer 71(6):e30964, 2024. e-Pub 2024. PMID: 38514796.
32. Gibson A, Nunez C, Robusto L, Kammerer B, Garcia M, Roth M, Sheth R, Tewari P, Hittle A, Toepfer L, Torres R, Short NJ, Jabbour E, Jain N, Cuglievan B, McCall D. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica, 2024. e-Pub 2024. PMID: 38779719.
33. Sheikh IN, AlQahtani S, Yin CC, McCall D, Cuglievan B, Ragoonanan D, Connors JS, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia MB. KIT-mutated pediatric core-binding factor systemic mastocytosis-acute myeloid leukemia treated with avapritinib and decitabine. Pediatr Blood Cancer 71(4):e30898, 2024. e-Pub 2024. PMID: 38291730.
34. Sarkar S, Stitzlein LM, Rav E, Garcia MB, Razvi S, Chang M, Zakhour R. Case series: Stenotrophomonas maltophilia in pediatric oncology patients. Cancer Rep (Hoboken) 7(3):e1982, 2024. e-Pub 2024. PMID: 38419283.
35. Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, Wang Z, Borges P, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Garza AI, Nasnas C, Vaughn NR, Baran N, Deng Q, Matthews J, Gunaratne PH, Antunes DA, Ekmekcioglu S, Sasaki K, Garcia MB, Cuglievan B, Hao D, Daver N, Green MR, Konopleva M, Futreal A, Post SM, Abbas HA. Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nature Communications 15(1), 2024. e-Pub 2024. PMID: 38418901.
36. He J, Munir F, Catueno S, Connors JS, Gibson A, Robusto L, McCall D, Nunez C, Roth M, Tewari P, Garces S, Cuglievan B, Garcia MB. Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers (Basel) 16(5), 2024. e-Pub 2024. PMID: 38473221.
37. He J, Garcia MB, Connors JS, Nuñez CA, Quesada AE, Gibson A, Roth M, Cuglievan B, Pemmaraju N, McCall D. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. J Pediatr Hematol Oncol 45(8):e1001-e1004, 2023. e-Pub 2023. PMID: 37661300.
38. Cuglievan B, Connors J, He J, Khazal S, Yedururi S, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D, Petropoulos D, Tewari P, Nunez C, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J, Daver N, Gangat N, Konopleva M, Meshinchi S, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia 37(9):1767-1778, 2023. e-Pub 2023. PMID: 37452102.
39. Garcia MB, Schadler KL, Chandra J, Clinton SK, Courneya KS, Cruz-Monserrate Z, Daniel CR, Dannenberg AJ, Demark-Wahnefried W, Dewhirst MW, Fabian CJ, Hursting SD, Irwin ML, Iyengar NM, McQuade JL, Schmitz KH, Basen-Engquist K. Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancer. CA Cancer J Clin 73(4):425-442, 2023. e-Pub 2023. PMID: 36825928.
40. Swizer KN, Beebe M, Garcia MB. Successful first-line treatment of hemophagocytic lymphohistiocytosis with ruxolitinib in a pediatric patient with trisomy 21. Pediatr Blood Cancer 70(6):e30241, 2023. e-Pub 2023. PMID: 36734403.
41. Purcell SA, Kok DE, Ketterl T, Garcia MB, Joffe L, Brown JC, Dieli-Conwright CM, Williams GR. Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition. J Natl Cancer Inst Monogr 2023(61):3-11, 2023. e-Pub 2023. PMID: 37139976.
42. Munir F, He J, Connors J, Garcia M, Gibson A, McCall D, Nunez C, Dinh CN, Robusto L, Roth M, Khazal S, Tewari P, Cuglievan B. Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Translational Pediatrics, 2023. e-Pub 2023. PMID: 37035397.
43. Trabal A, Gibson A, He J, McCall D, Roth M, Nuñez C, Garcia M, Buzbee M, Toepfer L, Bidikian A, Daver N, Kadia T, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garces S, Marcogliese A, Paek H, Dreyer Z, Brackett J, Redell M, Yi J, Garcia-Manero G, Konopleva M, Stevens A, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers 15(7), 2023. e-Pub 2023. PMID: 37046645.
44. Garcia M, Schadler K. The Role of Exercise and Physical Activity in Osteosarcoma for Patients and Survivors. Journal of Cancer Biology 1(2):48-52, 2020. e-Pub 2020.
45. Marmonti E, Savage H, Zhang A, Morrell MG, Bedoya CAF, Harden A, Buzbee M, Schadler K. Modulating sphingosine-1-phosphate receptors to improve chemotherapy efficacy against Ewing sarcoma. International Journal of Cancer 147(4):1206-1214, 2020. e-Pub 2020. PMID: 31922252.
46. Ramanathan S, Garcia M, Menon N, Mazur L. Epidural Bleed in Infant with Hemophilia. Contemporary Pediatrics 37(6):131-133, 2020. e-Pub 2020.
47. Garcia MB, Ness KK, Schadler KL. Exercise and Physical Activity in Patients with Osteosarcoma and Survivors. Adv Exp Med Biol 1257:193-207, 2020. e-Pub 2020. PMID: 32483741.
48. Morrell MBG, Baker R, Johnson A, Santizo R, Liu D, Moody K. Dietary intake and micronutrient deficiency in children with cancer. Pediatric Blood Cancer 66(10), 2019. e-Pub 2019. PMID: 31286672.
49. Morrell MBG, Alvarez-Florez C, Zhang A, Kleinerman ES, Savage H, Marmonti E, Park M, Shaw A, Schadler KL. Vascular modulation through exercise improves chemotherapy efficacy in Ewing sarcoma. Pediatric Blood Cancer 66(9), 2019. e-Pub 2019. PMID: 31136074.
50. Zhang A, Zeng X, Woo JJ, Morrell M, Xu D. An unusual case of Herlyn-Werner-Wunderlich syndrome with a complete septate uterus and complicated urinary tract with rare ectopic ureteral opening. International Journal of Gynecology & Obstetrics 143(2):248-250, 2018. e-Pub 2018. PMID: 29959772.
51. Shaw A*, Morrell M*, Weissferdt A, Hayes-Jordan A, Harrison D. Malignant Transformation of Testicular Teratoma to PNET, Adenocarcinoma, and Osteosarcoma with Complete Remission after Surgery and Combination Chemotherapy in a Young Adult Male. Case Reports Oncological Medicine 2018:8460603, 2018. e-Pub 2018. PMID: 30402315.

Professional Educational Materials

1. . The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Children's Oncology Group, 2018.

Abstracts

1. Vitiello A, Roth M, Catueno C, Gibson A, McCall D, Nunez C, Garcia MB, Cuglievan B. Menin Inhibition Enables Curative-Intent Transplantation in High-Risk Cohort of NUP98-Rearranged AML. Summer in Oncology at Anderson Research (SOAR) Program Research Symposium, 2026. e-Pub 2026.
2. Short N, Maroun M, Dinardo C, Garcia M, McCall D, Cuglievan B, Karrar O, Hachem M, Qia W, Huang X, Ohanian M, Ferrajoli A, Takahashi K, Swaminathan M, Stevens K, Jabbour E, Kantarjian H. Combination therapy with blinatumomab and asciminib for Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from a phase I/II study. EHA Congress 2026, European Hematology Association. e-Pub 2026.
3. Cuglievan B, Jen WY, Short N, Bataller A, DiNardo C, Loghavi S, Daver N, Farhat A, El Hajjar G, McCall D, Gibson A, Garcia MB, Nunez C, Roth M, Tapan MK, Bazinet A, Jabbour E, Montalban-Bravo G, Ravandi F, Garcia-Manero G, Andreeff M, Kantarjian HM, Issa GC. Phase I/II Study of the All-Oral Combination of Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax (SAVE) in R/R AML. EHA Congress 2026, European Hematology Association. e-Pub 2026.
4. Hernandez Botero AM, Hsu A, Cuglievan B, McCall D, Gibson M, Garcia MB, Sheth RK, Boren R, Nunez C. Immunotherapy in Panniculitis-like T Cell Lymphoma. ASPHO Annual Meeting, 2026. e-Pub 2026.
5. AlQanber B, Cuglievan B, Gibson A, Garcia MB, McCall D, Nunez C. Immunotherapy with Polatuzumab and Glofitamab for Pediatric Refractory Burkitt Lymphoma. ASPHO Annual Meeting, 2026. e-Pub 2026.
6. Khazaei S, Nair S, Munir F, Calkins P, Threat D, Mizuno H, Ostermann L, Garcia MB, Cuglievan B, Stevens AM, Andreef M, Nishida Y. Protein degradation of MYC/GSPT1 combined with menin inhibition overcomes resistance to menin inhibition in KMT2A-rearranged Acute Myeloid Leukemia. ASH Annual Meeting, 2025. e-Pub 2025.
7. Garza M, Khazaei S, Munir F, Calkins P, Threat D, Mizuno H, Ostermann L, Cuglievan B, Garcia MB, Ma L, Andreef M, Nishida Y. Protein degradation of MYC/GSPT1 is a novel treatment modality for aggressive T-cell acute lymphoblastic leukemias. Ash Annual Meeting, 2025. e-Pub 2025.
8. Sheikh I, Raj R, Okeleji O, Catueno S, Fan A, McCall D, Gibson A, Garcia MB, Conners J, Roth M, Nunez C, Petropoulos D, Cuglievan B, Tewari P. Positive outcomes associated with stem cell transplantation in pediatric/AYA patients who receive FLAG-IDA-venetoclax for high-risk AML. ASH Annual Meeting, 2025. e-Pub 2025.
9. McCall D, Hittle A, Cuglievan B, Jabbour E, Short N, Nitin J, Catueno S, Garcia MB, Nunez C, Roth M, Toepfer L, Torres R, Gibson A. Next-generation sequencing as a powerful tool for measurable residual disease assessment in pediatrics: Identifying time points of true remission. ASH Annual Meeting, 2025. e-Pub 2025.
10. Catueno S, Okeleji O, McCall D, Farhat A, Hajjar G, Boren R, Sheth R, Garcia MB, Gibson A, Jen W, Senapati J, Garces S, Loghavi S, Tang G, Nunez C, Roth M, Aggarwal A, Kadia T, Jabbour E, Daver N, Short N, Garcia-Manero G, DiNardo C, Issa G, Cuglievan B. Cardiac safety of revumenib in children with HOX-driven leukemia: A single-institution cohort. ASH Annual Meeting, 2025. e-Pub 2025.
11. Chohan K, Feng L, Cochran H, Rosenberg M, Isenalumhe L, Yilmaz E, Kim S, Tiger Y, Torka P, Flanagan H, Castellino S, Bender J, Kannaiyan R, Kahla J, DePriest P, Narvel H, Catueno S, Tobon K, Fadul J, Faulkenberry P, Ayers A, Nathan S, Mubeen S, Luttwak E, Flerlage J, Norris R, Kaur S, Tran O, Wannaphut C, Hawk A, Garcia MB, Cuglievan B, Riedell P, Mahadeo K, Hamadani M, Diefenbach C, Bartlett N, Ahmed S. Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma. ASH Annual Meeting, 2025. e-Pub 2025.
12. Cuglievan B, Okeleji O, Catueno S, McCall D, Garcia MB, Gibson A, Nunez C, Roth M, Farhat A, El Hajjar G, Garces S, Balch A, Stevens A, Yi J, Sasaki K, Sheikh I, Conners J, Petropoulos D, Tewari P, Issa G. Post-transplant maintenance with revumenib in children with HOX-driven AML. ASH Annual Meeting, 2025. e-Pub 2025.
13. Elgehiny A, Elsamny E, Gibson A, McCall D, Cuglievan B, Nunez C, Swinford R, Garcia MB. Hematuria in a Pediatric Patient with Leukemia: When back pain becomes a double-edged clue. ASHPO Annual Meeting, 2025. e-Pub 2025.
14. Frost M, Raj R, Catueno S, Gibson A, Garcia MB, Roth M, Nunez C, Cuglievan B, McCall D. Peripheral Eosinophilia In Pediatric Acute Lymphoblastic Leukemia Patients Receiving Blinatumomab. ASPHO Annual Meeting, 2025. e-Pub 2025.
15. Nair S, Khazaei S, Ostermann LB, Mizuno H, Yee Mak P, Carter BZ, Boettcher S, Ma L, Garcia MB, Cuglievan B, Andreef M, Nishida Y. KMT2Ar AML is Vulnerable to the Combinatorial Inhibition of Menin and MYC Protein Degradation. AACR Annual Meeting, 2025. e-Pub 2025.
16. Raj R, Gibson A, McCall D, Cuglievan B, Nunez C, Roth M, Garcia MB. Neurotoxicity in Pediatric ALL: Insights into Methotrexate-Associated Risk Factors, Timing, Management Strategies. ASHPO Annual Meeting, 2025. e-Pub 2025.
17. Frost M, Catueno S, Raj R, Gibson A, Garcia MB, Roth M, Nunez C, Cuglievan B, McCall D. Pleocytosis in Cerebrospinal Fluid During Blinatumomab Therapy in Pediatric B-ALL: A Retrospective Review. ASPHO Annual Meeting, 2025. e-Pub 2025.
18. Raj, R, Catueno, A, Gibson, A, McCall, D, Garcia MB, Nunez, C, Roth, M, Sasaki, K, Tewari, P, Cuglievan, B, DiNardo, CD. FLAG IDA Venetoclax in Newly Diagnosed Pediatric and AYA Patients with AML. ASH Annual Meeting, 2024. e-Pub 2024.
19. Ly, CP, Veletic, I, Pacheco, CD, Dasdemir, E, Jelloul, F, Ferri-Borgogno, S, Basi, A, Gomez, J, Root, JL, Reville, P, Quesada, A, Bueso-Ramos, CE, Garcia MB, Burks, JK, Abbas, HA. Multimodal Spatial Profiling in Acute Myeloid Leukemia. ASH Annual Meeting, 2024. e-Pub 2024.
20. McCall D, Gibson, A, Garcia MB, Nunez, C, Cuglievan, B. A Phase I Study Investigating Combination of the Ziftomenib, Venetoclax, and Azacitdine (ZiVA) in Pediatric Relapsed and Refractory Acute Leukemias. ASH Annual Meeting, 2024. e-Pub 2024.
21. Ramakrishnan R, Okeleji O, Gibson A, Nunez C, Roth M, Garcia MB, Cuglievan B, McCall D. Successful Treatment of Relapsed Pediatric B-ALL Harboring TCF3-HLF Fusion Transcript with Pedi-cRIB Regimen. COG Fall Meeting, 2024. e-Pub 2024.
22. Catueno S, Nash, A, Wanes P, McCall d, Garcia MB, Roth M, Nunez C, Cuglievan B, Gibson A. Use of Immunotherapy and Targeted Therapy in EPOR-IGH BALL. COG Fall Meeting, 2024. e-Pub 2024.
23. Raj R, Ramakrishnan R, McCall D, Gibson A, Cuglievan B, Nunez C, Brown B, Bray A, Garcia MB. Hemophagocytic Lymphohistiocytosis in an Infant with Confounding Primary and Secondary Diagnostic Factors. COG Fall meeting, 2024. e-Pub 2024.
24. Alqahtani S, Budak M, Cuglievan B, Nunez C, Roth M, Garcia M, Gibson A, McCall D. Cladribine use in Pediatric Relapsed Leukemias: The MD Anderson Cancer Center Experience. ASPHO Annual Meeting, 2024. e-Pub 2024.
25. Sheikh I, AlQahtani S, Cameron CY, Ragoonanan D, Cuglievan B, McCall D, Gibson A, Nunez C, Roth M, Ohanian M, Borthakur G, Garcia M. Avapritinib and Decitabine in an Adolescent with CBF SM-AML. ASPHO Annual Meeting, 2024. e-Pub 2024.
26. He J, Munir, Ayerbe C, Dickson S, Catueno S, Garcia M, Gibson A, McCall D, Nunez C, Roth M, Tewari P, Cuglievan B, Cortes J. Management of Acquired Hypofibrinogenemia in Children with Leukemia. ASPHO Annual Meeting, 2024. e-Pub 2024.
27. Rav E, Sarkar SD, Stitzlein L, Gibson A, McCall D, Nunez C, Roth M, Cuglievan B, Herzog C, Garcia M. Therapy Related KMT2A Rearranged Leukemia Treated Using Palbociclib and Blinatumomab. ASPHO Annual Meeting, 2024. e-Pub 2024.
28. Catueno S, Garcia M, McCall D, Nunez C, Cuglievan B, Gibson A. Management of CNS Diffuse Large B Cell Lymphoma in a Patient with Ataxia Telangiectasia. ASPHO Annual Meeting, 2024. e-Pub 2024.
29. Lucas B, Connors J, Conneely S, Cuglievan B, Garcia M*, Rau R*. Observation and Management of JMML: A Texas Medical Center Experience. ASPHO Annual Meeting, 2024. e-Pub 2024.
30. Alqahtani S, Ramakrishnan R, Nunez C, McCall D, Garcia MB, Cuglievan B, Gibson A. Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia. ASH Annual Meeting, 2023. e-Pub 2023.
31. Ghayas I, Cuglievan B, DiNardo C, Short N, McCall D, Gibson A, Nunez C, Garcia M, Roth M, Bidikian A, Pike A, Tan S, Kammerer B, Yilmaz M, Kadia T, Pemmaraju N, Ohanian M, Daver N, Jabbour E, Borthakur G, Ravandi R, Garcia-Manero G, Andreeff M, Kantarjian H. Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE). ASH Annual Meeting, 2023. e-Pub 2023.
32. Munir F, Khazei S, Calkins P, Scruggs DA, Mizuno H, Ostermann LB, Cuglievan B, Garcia M, Chen D, Tong Y, Ren Z, Andreeff M, Nishida Y. Targeted Protein Degradation for c-MYC Overcomes Therapy Resistance in T-Cell Acute Lymphoblastic Leukemias. ASH Annual Meeting, 2023. e-Pub 2023.
33. Wang B, Reville P, Yassouf Y, Jelloul F, Desai P, Wang Z, Borges P, Ly C, Veletic I, Dasdemir E, Burks J, Tang G, Guo S, Garza A, Nasnas C, Vaugh NR, Baran N, Deng Q, Matthews J, Gunaratne P, Antunes D, Ekmekcloglu S, Sasaki K, Garcia M, Cuglievan B, Hao D, Daver N, Green M, Konopleva M, Futreal A, Post S, Abbas H. IFNy Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies. ASH Annual Meeting, 2023. e-Pub 2023.
34. Nunez C, Cuglievan B, Ravandi F, Doherty E, Redell M, McCall D, Gibson A, Garcia M, Roth M, Robusto L, Sheth R, Rabin K, Short N. Successful treatment with response-adjusted Venetoclax dosing in combination with Azacytidine and Gilteritinib in FLT3-ITD positive refractory AML. SIOP Annual Meeting, 2023. e-Pub 2023.
35. Stevens K, Garcia M, Moody K, Kresta K, Gonzalez Villarreal E, Waterman G, Mama S, Swartz M. Identifying the Prevalence of Vitamin C Deficiency and Examining the Associated Factors in Children, Adolescents, and Young Adults with Cancer. Cancer Prevention Research Training Program Exposition, 2023. e-Pub 2023.
36. He J, Gibson A, Cesar N, Cuglievan B, Munir F, Roth M, Garcia M, McCall D. Successful treatment of malignancy-associated hemophagocytic lymphohistiocytosis in a teenager. ASPHO Annual Meeting, 2023. e-Pub 2023.
37. He J, McCall D, Garcia M, Nunez C, Gibson A, Cuglievan B, Connors J, Roth M. Remission with an Adult Regimen in a Teenager with Blastic Plasmacytoid Dendritic Cell Neoplasm. ASPHO Annual Meeting, 2023. e-Pub 2023.
38. Okeleji O, McCall D, Gibson A, Cesar N, Cuglievan B, Garcia M, Roth M. Early Unfavorable Classic Hodgkin Lymphoma Treated with A+AVD in a Pediatric Patient. ASPHO Annual Meeting, 2023. e-Pub 2023.
39. Griffin TC, Cheek NL, Wolfe A, Sanchez D, Voeller J, Garcia M, Andreansky M, Hemmeger JM, Clarke PA, Calderon L. COVID-19 Infection in Hematology/Oncology/BMT Patients at The Children's Hospital of San Antonio. Children’s Hospital of San Antonio Symposium, 2021. e-Pub 2021.
40. Garcia M, Ocampo R, Quezada G, Chandra J. Measuring the Clinical and Psychosocial Impact of the CHEF Teaching Kitchen in Pediatric Cancer Patients and Survivors. Children’s Hospital of San Antonio Symposium, 2021. e-Pub 2021.
41. Garcia M, Ocampo R, Quezada G, Chandra J. Measuring the Clinical and Psychosocial Impact of the CHEF Teaching Kitchen in Pediatric Cancer Patients and Survivors. Translating Energy Balance From Bench to Communities: Application of Parallel Animal-Human Studies in Cancer Virtual Conference, 2021. e-Pub 2021.
42. Morrell M, Baker R, Johnson A, Santizo R, Liu D, Moody K. Dietary Intake and Micronutrient Deficiency in Children with Cancer. ASPHO Annual Meeting, 2019. e-Pub 2019.
43. Khatua S, Chandra J, Morrell M, Meador H, Sandberg D, Weignberg J, Fuller G, Ketonen L, Johnson J, Gopalakrishnan V, Hess K, Zaky W. A phase I study of Suberoylanilide Hydroxamic Acid (SAHA) with Temsirolimus in children with newly diagnosed or progressive diffuse intrinsic pontine glioma. American Association for Cancer Research (AACR) Annual Meeting, 2019. e-Pub 2019.
44. Morrell M, Alvarez Florez C, Zhang A, Savage H, Shaw A, Kleinerman E, Schadler K. Sphingosine-1-Phosphate Receptor 2 Modulation through Exercise to Improve Chemotherapy Efficacy in Ewing Sarcoma. 2018 Vascular Research Consortium, 2018. e-Pub 2018.
45. Morrell M, Zhang A, Jensen V, Alvarez C, Schadler K. Exercise Impacts Tumor Vasculature and Metastasis in Ewing Sarcoma. Connective Tissue Oncology Society (CTOS) Annual Meeting, 2017. e-Pub 2017.
46. Morrell M, Zhang A, Jensen V, Alvarez C, Schadler K. Exercise Impacts Tumor Vasculature and Metastasis in Ewing Sarcoma. Children's Oncology Group (COG) Fall Meeting, 2017. e-Pub 2017.
47. Khatua S, Gopalakrishnan V, Chandra J, Ketonen L, Sandberg D, Weignberg J, Fuller G, Hess K, Meador H, Morrell M, Slone N, Zaky W. A phase I study of Vorinostat and Temsirolimus in children with newly diagnosed or progressive diffuse intrinsic pontine glioma. Global Academic Programs Annual Conference, 2017. e-Pub 2017.
48. Shaw A, Morrell M, Weissferdt A, Harrison D. Malignant Transformation of Testicular Teratoma to Primitive Neuroectodermal Tumor, Adenocarcinoma, and Osteosarcoma with Complete Remission after Surgery and Combination Therapy. ASPHO Annual Meeting, 2017. e-Pub 2017.
49. Khatua S, Gopalakrishnan V, Chandra J, Ketonen L, Sandberg D, Weignberg J, Fuller G, Hess K, Meador H, Morrell M, Slone N, Zaky W. A phase I study of Vorinostat and Temsirolimus in children with newly diagnosed or progressive diffuse intrinsic pontine glioma. American Association for Cancer Research (AACR) Annual Meeting, 2017. e-Pub 2017.
50. Morrell M, Cuglievan B, Livingston J, Huh W, Ater J. Adolescent and Young Adult Survivors of Pediatric Bone Sarcomas and Bone Health. Texas Adolescent and Young Adult Conference, 2017. e-Pub 2017.
51. Shaw A, Morrell M, Weissferdt A, Harrison D. Malignant Transformation of Testicular Teratoma to Primitive Neuroectodermal Tumor, Adenocarcinoma, and Osteosarcoma with Complete Remission after Surgery and Combination Therapy. Texas Adolescent and Young Adult Conference, 2017. e-Pub 2017.
52. Morrell M, Cuglievan B, Livingston J, Huh W, Ater J. Adolescent and Young Adult Survivors of Pediatric Bone Sarcomas and Bone Health. Cancer Survivorship Research Symposium, 2017. e-Pub 2017.
53. Morrell M, Garcia-Frausto E, Assanasen C. Pancreatitis due to Mercaptopurine and Asparaginase in Acute Lymphoblastic Leukemia. Texas Pediatric Society, 2014. e-Pub 2014.

Book Chapters

1. Garcia MB, Runco D. Nutrition and Cancer. In: Pediatric Nutrition. 9th. American Academy of Pediatrics, 2025.
2. Giles E, Dolgoy ND, Dieli-Conwright C, Benzo RM, Bhandari R, Caru M, Christopher C, Fairman CM, Garcia MB, Loomans-Kropp H, Moraitis AM, Playdon M, Swartz MC, Skiba MB, Kim S, Irwin M, Doan H. Lifestyle and Cancer Prevention. In: Abeloff’s Clinical Oncology. 7th, 2025.
3. Garcia MB, Ness KK, Schadler KL. Exercise and Physical Activity in Patients with Osteosarcoma and Survivors. In: Current Advances in Osteosarcoma. Springer, 193-207, 2020.